Report cover image

Global SNP Microarray Testing and Analysis Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Dec 28, 2025
Length 205 Pages
SKU # APRC20795067

Description

The global SNP Microarray Testing and Analysis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of SNP Microarray Testing and Analysis include Thermo Fisher Scientific, Illumina, Agilent, Roche, Bio-Rad, CD Genomics, Ambry Genetics, Labcorp and Allele Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for SNP Microarray Testing and Analysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of SNP Microarray Testing and Analysis, also provides the revenue of main regions and countries. Of the upcoming market potential for SNP Microarray Testing and Analysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the SNP Microarray Testing and Analysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global SNP Microarray Testing and Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for SNP Microarray Testing and Analysis revenue, projected growth trends, production technology, application and end-user industry.

SNP Microarray Testing and Analysis Segment by Company

Thermo Fisher Scientific
Illumina
Agilent
Roche
Bio-Rad
CD Genomics
Ambry Genetics
Labcorp
Allele Diagnostics
Sonic Genetics
Invitae
Genetics Generation Advancement (GGA)
Quest Diagnostics
CapitalBio
HNL Lab Medicine
Psomagen
VCGS
Genetics Associates

SNP Microarray Testing and Analysis Segment by Type

Whole Genome SNP Microarrays
Custom SNP Microarrays

SNP Microarray Testing and Analysis Segment by Application

Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Other

SNP Microarray Testing and Analysis Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SNP Microarray Testing and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of SNP Microarray Testing and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SNP Microarray Testing and Analysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of SNP Microarray Testing and Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of SNP Microarray Testing and Analysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SNP Microarray Testing and Analysis revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

205 Pages
1 Market Overview
1.1 Product Definition
1.2 SNP Microarray Testing and Analysis Market by Type
1.2.1 Global SNP Microarray Testing and Analysis Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Whole Genome SNP Microarrays
1.2.3 Custom SNP Microarrays
1.3 SNP Microarray Testing and Analysis Market by Application
1.3.1 Global SNP Microarray Testing and Analysis Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Pharmaceuticals and Pharmacogenomics
1.3.3 Diagnostic Research
1.3.4 Agricultural Biotechnology
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 SNP Microarray Testing and Analysis Market Dynamics
2.1 SNP Microarray Testing and Analysis Industry Trends
2.2 SNP Microarray Testing and Analysis Industry Drivers
2.3 SNP Microarray Testing and Analysis Industry Opportunities and Challenges
2.4 SNP Microarray Testing and Analysis Industry Restraints
3 Global Growth Perspective
3.1 Global SNP Microarray Testing and Analysis Market Perspective (2021-2032)
3.2 Global SNP Microarray Testing and Analysis Growth Trends by Region
3.2.1 Global SNP Microarray Testing and Analysis Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global SNP Microarray Testing and Analysis Market Size by Region (2021-2026)
3.2.3 Global SNP Microarray Testing and Analysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global SNP Microarray Testing and Analysis Revenue by Players
4.1.1 Global SNP Microarray Testing and Analysis Revenue by Players (2021-2026)
4.1.2 Global SNP Microarray Testing and Analysis Revenue Market Share by Players (2021-2026)
4.1.3 Global SNP Microarray Testing and Analysis Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global SNP Microarray Testing and Analysis Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global SNP Microarray Testing and Analysis Key Players Headquarters & Area Served
4.4 Global SNP Microarray Testing and Analysis Players, Product Type & Application
4.5 Global SNP Microarray Testing and Analysis Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global SNP Microarray Testing and Analysis Market CR5 and HHI
4.6.3 2025 SNP Microarray Testing and Analysis Tier 1, Tier 2, and Tier 3
5 SNP Microarray Testing and Analysis Market Size by Type
5.1 Global SNP Microarray Testing and Analysis Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
5.3 Global SNP Microarray Testing and Analysis Revenue Market Share by Type (2021-2032)
6 SNP Microarray Testing and Analysis Market Size by Application
6.1 Global SNP Microarray Testing and Analysis Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
6.3 Global SNP Microarray Testing and Analysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.1.4 Thermo Fisher Scientific SNP Microarray Testing and Analysis Product Portfolio
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Illumina
7.2.1 Illumina Company Information
7.2.2 Illumina Business Overview
7.2.3 Illumina SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.2.4 Illumina SNP Microarray Testing and Analysis Product Portfolio
7.2.5 Illumina Recent Developments
7.3 Agilent
7.3.1 Agilent Company Information
7.3.2 Agilent Business Overview
7.3.3 Agilent SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.3.4 Agilent SNP Microarray Testing and Analysis Product Portfolio
7.3.5 Agilent Recent Developments
7.4 Roche
7.4.1 Roche Company Information
7.4.2 Roche Business Overview
7.4.3 Roche SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.4.4 Roche SNP Microarray Testing and Analysis Product Portfolio
7.4.5 Roche Recent Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Company Information
7.5.2 Bio-Rad Business Overview
7.5.3 Bio-Rad SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.5.4 Bio-Rad SNP Microarray Testing and Analysis Product Portfolio
7.5.5 Bio-Rad Recent Developments
7.6 CD Genomics
7.6.1 CD Genomics Company Information
7.6.2 CD Genomics Business Overview
7.6.3 CD Genomics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.6.4 CD Genomics SNP Microarray Testing and Analysis Product Portfolio
7.6.5 CD Genomics Recent Developments
7.7 Ambry Genetics
7.7.1 Ambry Genetics Company Information
7.7.2 Ambry Genetics Business Overview
7.7.3 Ambry Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.7.4 Ambry Genetics SNP Microarray Testing and Analysis Product Portfolio
7.7.5 Ambry Genetics Recent Developments
7.8 Labcorp
7.8.1 Labcorp Company Information
7.8.2 Labcorp Business Overview
7.8.3 Labcorp SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.8.4 Labcorp SNP Microarray Testing and Analysis Product Portfolio
7.8.5 Labcorp Recent Developments
7.9 Allele Diagnostics
7.9.1 Allele Diagnostics Company Information
7.9.2 Allele Diagnostics Business Overview
7.9.3 Allele Diagnostics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.9.4 Allele Diagnostics SNP Microarray Testing and Analysis Product Portfolio
7.9.5 Allele Diagnostics Recent Developments
7.10 Sonic Genetics
7.10.1 Sonic Genetics Company Information
7.10.2 Sonic Genetics Business Overview
7.10.3 Sonic Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.10.4 Sonic Genetics SNP Microarray Testing and Analysis Product Portfolio
7.10.5 Sonic Genetics Recent Developments
7.11 Invitae
7.11.1 Invitae Company Information
7.11.2 Invitae Business Overview
7.11.3 Invitae SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.11.4 Invitae SNP Microarray Testing and Analysis Product Portfolio
7.11.5 Invitae Recent Developments
7.12 Genetics Generation Advancement (GGA)
7.12.1 Genetics Generation Advancement (GGA) Company Information
7.12.2 Genetics Generation Advancement (GGA) Business Overview
7.12.3 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.12.4 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Product Portfolio
7.12.5 Genetics Generation Advancement (GGA) Recent Developments
7.13 Quest Diagnostics
7.13.1 Quest Diagnostics Company Information
7.13.2 Quest Diagnostics Business Overview
7.13.3 Quest Diagnostics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.13.4 Quest Diagnostics SNP Microarray Testing and Analysis Product Portfolio
7.13.5 Quest Diagnostics Recent Developments
7.14 CapitalBio
7.14.1 CapitalBio Company Information
7.14.2 CapitalBio Business Overview
7.14.3 CapitalBio SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.14.4 CapitalBio SNP Microarray Testing and Analysis Product Portfolio
7.14.5 CapitalBio Recent Developments
7.15 HNL Lab Medicine
7.15.1 HNL Lab Medicine Company Information
7.15.2 HNL Lab Medicine Business Overview
7.15.3 HNL Lab Medicine SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.15.4 HNL Lab Medicine SNP Microarray Testing and Analysis Product Portfolio
7.15.5 HNL Lab Medicine Recent Developments
7.16 Psomagen
7.16.1 Psomagen Company Information
7.16.2 Psomagen Business Overview
7.16.3 Psomagen SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.16.4 Psomagen SNP Microarray Testing and Analysis Product Portfolio
7.16.5 Psomagen Recent Developments
7.17 VCGS
7.17.1 VCGS Company Information
7.17.2 VCGS Business Overview
7.17.3 VCGS SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.17.4 VCGS SNP Microarray Testing and Analysis Product Portfolio
7.17.5 VCGS Recent Developments
7.18 Genetics Associates
7.18.1 Genetics Associates Company Information
7.18.2 Genetics Associates Business Overview
7.18.3 Genetics Associates SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
7.18.4 Genetics Associates SNP Microarray Testing and Analysis Product Portfolio
7.18.5 Genetics Associates Recent Developments
8 North America
8.1 North America SNP Microarray Testing and Analysis Revenue (2021-2032)
8.2 North America SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
8.2.1 North America SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
8.2.2 North America SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
8.3 North America SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
8.4 North America SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
8.4.1 North America SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
8.4.2 North America SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
8.5 North America SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
8.6 North America SNP Microarray Testing and Analysis Revenue by Country
8.6.1 North America SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
8.6.3 North America SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe SNP Microarray Testing and Analysis Revenue (2021-2032)
9.2 Europe SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
9.2.1 Europe SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
9.2.2 Europe SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
9.3 Europe SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
9.4 Europe SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
9.4.1 Europe SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
9.4.2 Europe SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
9.5 Europe SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
9.6 Europe SNP Microarray Testing and Analysis Revenue by Country
9.6.1 Europe SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
9.6.3 Europe SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China SNP Microarray Testing and Analysis Revenue (2021-2032)
10.2 China SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
10.2.1 China SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
10.2.2 China SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
10.3 China SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
10.4 China SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
10.4.1 China SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
10.4.2 China SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
10.5 China SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia SNP Microarray Testing and Analysis Revenue (2021-2032)
11.2 Asia SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
11.2.1 Asia SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
11.2.2 Asia SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
11.3 Asia SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
11.4 Asia SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
11.4.1 Asia SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
11.4.2 Asia SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
11.5 Asia SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
11.6 Asia SNP Microarray Testing and Analysis Revenue by Country
11.6.1 Asia SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
11.6.3 Asia SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA SNP Microarray Testing and Analysis Revenue (2021-2032)
12.2 SAMEA SNP Microarray Testing and Analysis Revenue by Type (2021-2032)
12.2.1 SAMEA SNP Microarray Testing and Analysis Revenue by Type (2021-2026)
12.2.2 SAMEA SNP Microarray Testing and Analysis Revenue by Type (2027-2032)
12.3 SAMEA SNP Microarray Testing and Analysis Revenue Share by Type (2021-2032)
12.4 SAMEA SNP Microarray Testing and Analysis Revenue by Application (2021-2032)
12.4.1 SAMEA SNP Microarray Testing and Analysis Revenue by Application (2021-2026)
12.4.2 SAMEA SNP Microarray Testing and Analysis Revenue by Application (2027-2032)
12.5 SAMEA SNP Microarray Testing and Analysis Revenue Share by Application (2021-2032)
12.6 SAMEA SNP Microarray Testing and Analysis Revenue by Country
12.6.1 SAMEA SNP Microarray Testing and Analysis Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA SNP Microarray Testing and Analysis Revenue by Country (2021-2026)
12.6.3 SAMEA SNP Microarray Testing and Analysis Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.